|
|
|
Company Name
|
Cell Therapeutics Inc.
|
|
Drug Name
|
PIXUVRI (NDA resubmission)
|
|
Event Name
|
FDA decision on PIXUVRI (pixantrone) to treat relapsed or refractory aggressive non-Hodgkin's lymphoma in patients
|
|
Event Date
|
04/24/2012
|
|
Outcome
|
PIXUVRI NDA voluntarily withdrawn by company. To be resubmitted in 2012
|
|
Drug Status
|
|
|
Rival Drugs
|
|
|
Market Potential
|
|
|
Other Approvals
|
|
|
News |
|
|
|
Return to FDA Calendar
|